What Is Targeted Temperature Management?
Targeted temperature management (TTM), formerly called therapeutic hypothermia, involves controlling a patient's body temperature after return of spontaneous circulation (ROSC) from cardiac arrest. The goal is to reduce the metabolic demand of the brain and other organs, minimize reperfusion injury, and improve neurological outcomes. TTM has become a standard component of post-cardiac arrest care in many EMS and hospital systems.
The Science Behind TTM
When the heart stops, the brain begins to suffer ischemic injury within minutes. Even after circulation is restored, a cascade of harmful processes (reperfusion injury) continues to damage brain cells. Cooling the body to a target temperature range slows these destructive processes by:
- Reducing cerebral metabolic rate and oxygen demand
- Decreasing the production of harmful free radicals
- Limiting the inflammatory response triggered by ischemia and reperfusion
- Reducing excitotoxic neurotransmitter release
- Stabilizing cell membranes and reducing edema
Prehospital TTM Initiation
The role of EMS in TTM varies by protocol. Some systems initiate cooling in the field after ROSC, while others focus on preventing hyperthermia (fever) during transport and leave active cooling to the receiving hospital. Common prehospital cooling methods include:
- Cold intravenous saline infusion (although rapid large-volume cold saline has fallen out of favor based on recent evidence)
- Surface cooling pads or ice packs applied to the neck, axillae, and groin
- Maintaining a cool ambulance environment
- Removing excess blankets and clothing
Current Guidelines and Controversies
The recommended target temperature range has evolved. Current guidelines from the AHA and ILCOR recommend targeting a temperature between 32 and 36 degrees Celsius for at least 24 hours after ROSC. The specific target temperature is typically determined by hospital protocol. In the prehospital setting, the primary focus should be on preventing fever (keeping the temperature below 37.5 degrees Celsius) and providing excellent post-ROSC care including hemodynamic support, oxygenation, and ventilation management.
Active prehospital cooling with rapid cold IV fluids is no longer recommended as routine practice based on evidence showing no neurological benefit and potential complications including rearrest. Follow your local protocols regarding TTM initiation in the field.